OpGen (OPGN) Momentum Rank : 9 (As of Apr. 29, 2024)

View and export this data going back to 2015. Start your Free Trial

What is OpGen Momentum Rank?

OpGen has the Momentum Rank of 9.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of OpGen's Momentum Rank

For the Medical Devices subindustry, OpGen's Momentum Rank, along with its competitors' market caps and Momentum Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OpGen's Momentum Rank Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OpGen's Momentum Rank distribution charts can be found below:

* The bar in red indicates where OpGen's Momentum Rank falls into.

OpGen Momentum Rank Related Terms

Thank you for viewing the detailed overview of OpGen's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

OpGen (OPGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OpGen Inc (NAS:OPGN) » Definitions » Momentum Rank

Comparable Companies

Traded in Other Exchanges

650:Germany

Address

9717 Key West Avenue, Suite 100, Rockville, MD, USA, 20850

Website

https://www.opgen.com

OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base.

Executives

Yvonne Schlaeppi	director	600 EAST GREENWICH AVENUE, WEST WARWICK X1 02893
Johannes Bacher	officer: Chief Operating Officer	9717 KEY WEST AVENUE, SUITE 101, ROCKVILLE MD 20850
Albert Weber	officer: Chief Finanical Officer	MARIENBURGER STR. 7, BERLIN 2M 10405
Oliver Schacht	director, officer: Chief Executive Officer	9717 KEY WEST AVENUE, SUITE 101, ROCKVILLE MD 20850
Evan/ Fa Jones	director, officer: Chief Executive Officer	C/O OPGEN, INC., 708 QUINCE ORCHARD ROAD, SUITE 205, GAITHERSBURG MD 20878
William E. Rhodes	director	C/O OPGEN, INC., 9717 KEY WEST AVE., SUITE 100, ROCKVILLE MD 20850
Curetis N.v. In Liquidation	10 percent owner	MAX-EYTH-STRASSE 42, HOLZGERLINGEN 2M 71088
Mario Crovetto	director	C/O OPGEN, INC., 9717 KEY WEST AVE., SUITE 100, ROCKVILLE MD 20850
Prabhavathi Fernandes	director	114 MILTON AVENUE, CHAPEL HILL NC 27514
Vadim M. Sapiro	officer: Chief Information Officer	C/O OPGEN, INC,, 708 QUINCE ORCHARD ROAD, SUITE 205, GAITHERSBURG MD 20878
Timothy C Dec	officer: Chief Financial Officer	C/O OPGEN, INC., 708 QUINCE ORCHARD ROAD, SUITE 205, GAITHERSBURG MD 20878
R Don Elsey	director	2273 RESEARCH BLVD, SUITE 400, ROCKVILLE MD 20850
Jven Capital, Llc	10 percent owner	P.O. BOX 60207, POTOMAC MD 20859
Tina Susan Nova	director	C/O ARENA PHARMACEUTICALS, INC., 6166 NANCY RIDGE DRIVE, SAN DIEGO CA 92121
Harry J D'andrea	director	6480 DOBBIN ROAD, COLUMBIA MD 21045